Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × INDUSTRY × capmatinib × Clear all

Phase

Phase 2 12 Phase 1 8 Phase 1/2 4 Phase 4 1 Phase 3 1

Status

Sponsor Class

OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 268 Paclitaxel 263 Cisplatin 213 Docetaxel 207 pembrolizumab 190 Gemcitabine 181 Pemetrexed 134 Rituximab 126 Capecitabine 124 Bevacizumab 119 Dexamethasone 103 Fluorouracil 98 Cyclophosphamide 91 Doxorubicin 90 Prednisone 85 Trastuzumab 84 Nivolumab 79 Oxaliplatin 75 atezolizumab 65 durvalumab 64 Leucovorin 59 Injections 59 Lenalidomide 56 130-nm albumin-bound paclitaxel 56 Irinotecan 49 Drug Therapy 48 Fulvestrant 46 Bortezomib 46 Letrozole 44 Bendamustine Hydrochloride 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04427072 2025-05-16

GeoMETry-III

Novartis

Phase 3 Terminated

22 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡